论文部分内容阅读
本文报告了80例无加杂症的阿米巴肝脓肿成人患者分别用Nitrimidazine(1-(N,β—ethyl-morpholine)-5-nitroimidazole)Tinidazole(ethyl(2—(2—methyl-1—5—nitro-1—imidazolyl)—ethyl)sulphone)、Ro7—0207(α-chloromethyl—2—methyl-5—nitro—1—imidazole ethanol)及Metronidazole(甲硝哒唑)治疗的疗效。治疗开始前,患者均经阿米巴琼脂扩散试验及检查肝脓液确诊。在住院观察的20天内,每天采用直接盐水涂片和硫酸漂浮法检查粪便。各组服药除每次剂量不同外,均每日3次,连服5天。治疗结果如下表:
In this paper, 80 adult patients without amyloidosis were treated with Nitriazine (1- (N, β-ethyl-morpholine) -5-nitroimidazole) 5-nitro-1-imidazolyl) -ethyl) sulphone), Ro7-0207 (α-chloromethyl-2-methyl-5-nitro-1-imidazole ethanol) and Metronidazole. Before treatment began, patients were confirmed by the amoebile agar diffusion test and liver pus. Within 20 days of in-hospital observation, faeces were examined daily using direct saline smear and sulfuric acid floatation. In addition to the dose of each group except for each dose, were 3 times a day, and even served 5 days. Treatment results are as follows: